Bridging the clinical gaps: genetic, epigenetic and transcriptomic biomarkers for the early detection of lung cancer in the post-National Lung Screening Trial era

Lung cancer is the leading cause of cancer death worldwide in part due to our inability to identify which smokers are at highest risk and the lack of effective tools to detect the disease at its earliest and potentially curable stage. Recent results from the National Lung Screening Trial have shown...

Descripción completa

Detalles Bibliográficos
Autores principales: Brothers, John F, Hijazi, Kahkeshan, Mascaux, Celine, El-Zein, Randa A, Spitz, Margaret R, Spira, Avrum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717087/
https://www.ncbi.nlm.nih.gov/pubmed/23870182
http://dx.doi.org/10.1186/1741-7015-11-168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717087/
https://www.ncbi.nlm.nih.gov/pubmed/23870182
http://dx.doi.org/10.1186/1741-7015-11-168

Ejemplares similares